| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |